Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis

Eline L Huisman,1 Sarah M Cockle,2 Afisi S Ismaila,3,4 Andreas Karabis,1 Yogesh Suresh Punekar2 1Mapi Group, Real World Strategy and Analytics and Strategic Market Access, Houten, the Netherlands; 2Value Evidence and Outcomes, GlaxoSmithKline, Uxbridge, UK; 3Value Evidence and Outcomes, GlaxoSmithK...

Full description

Bibliographic Details
Main Authors:	Huisman EL, Cockle SM, Ismaila AS, Karabis A, Punekar YS
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-09-01
Series:	International Journal of COPD
Online Access:	https://www.dovepress.com/comparative-efficacy-of-combination-bronchodilator-therapies-in-copd-a-peer-reviewed-article-COPD

Similar Items

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis
by: Ismaila AS, et al.
Published: (2015-11-01)

Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis
by: Karabis A, et al.
Published: (2013-09-01)

Comparative studies of dual bronchodilation in COPD
by: Mario Cazzola, et al.
Published: (2021-02-01)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
by: Jaco Voorham, et al.
Published: (2019-08-01)

Efficacy and safety of carvedilol in combination with bronchodilators in patients with CHF of ischemic origin and COPD.
by: Vladimir V. Evdokimov, et al.
Published: (2019-04-01)

Impact of bronchodilator therapy on exercise tolerance in COPD
by: B Aguilaniu
Published: (2010-03-01)

Experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2021-01-01)

Bronchodilators use in patients with COPD
by: Dong YH, et al.
Published: (2015-09-01)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
by: Strange C, et al.
Published: (2019-06-01)

Comparison of laboratory- and field-based exercise tests for COPD: a systematic review
by: Fotheringham I, et al.
Published: (2015-03-01)

Clinical experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2019-12-01)

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
by: Samyshkin Y, et al.
Published: (2013-01-01)

Optimizing bronchodilation in the prevention of COPD exacerbations
by: Marc Miravitlles, et al.
Published: (2017-06-01)

When is dual bronchodilation indicated in COPD?
by: Thomas M, et al.
Published: (2017-08-01)

Fixed-dose combinations of bronchodilators in the treatment of patients with COPD: problem of choice
by: A. I. Sinopalnikov
Published: (2018-10-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

DIFFERENTIATED APPROACH TO THE APPOINTMENT OF BRONCHODILATOR THERAPY IN PATIENTS WITH COPD. EXAMPLES FROM PRACTICE
by: G. L. Ignatova, et al.
Published: (2017-11-01)

The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD
by: Mahoto Kato, et al.
Published: (2017-12-01)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
by: Mario Cazzola, et al.
Published: (2019-11-01)

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study
by: Voduc N, et al.
Published: (2012-03-01)

Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis
by: Cope Shannon, et al.
Published: (2012-06-01)

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
by: Fabiano Di Marco, et al.
Published: (2018-01-01)

Effect of prednisolone on lung function and bronchodilator responses in stable COPD
by: Chhabra S, et al.
Published: (2006-01-01)

Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial
by: Ramírez-Venegas A, et al.
Published: (2019-08-01)

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
by: Pascoe S, et al.
Published: (2016-08-01)

Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study
by: Buhl R, et al.
Published: (2018-08-01)

Effect of perioperative bronchodilator therapy on postoperative pulmonary function among lung cancer patients with COPD
by: Sun Hye Shin, et al.
Published: (2021-04-01)

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial
by: F. Maltais, et al.
Published: (2020-10-01)

A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study
by: Juvelekian G, et al.
Published: (2015-10-01)

Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
by: Fabiano Di Marco, et al.
Published: (2018-04-01)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
by: Kozma Chris M, et al.
Published: (2011-12-01)

Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice
by: Р. A. Balunov, et al.
Published: (2019-01-01)

Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
by: Gong S, et al.
Published: (2021-02-01)

Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients
by: Yoshiaki Minakata, et al.
Published: (2020-10-01)

Bronchodilator response of advanced lung function parameters depending on COPD severity
by: Jarenbäck L, et al.
Published: (2016-11-01)

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
by: Decramer Marc, et al.
Published: (2011-01-01)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
by: José Alberto Neder, et al.

Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
by: Kang J, et al.
Published: (2017-12-01)

Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
by: Barjaktarevic I, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_b23v4lnbmmdcplbomfj6gai4h5